Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: Correlation with pathologic tumor volume

Radiology

Volumn 252, Issue 2, 2009, Pages 449-457

  Mazaheri, Yousef ^a   Hricak, Hedvig ^a   Fine, Samson W ^a   Akin, Oguz ^a   Shukla Dave, Amita ^a   Ishill, Nicole M ^a   Moskowitz, Chaya S ^a   Grater, Joanna E ^a   Reuter, Victor E ^a   Zakian, Kristen L ^a   Touijer, Karim A ^a   Koutcher, Jason A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; PROSTATECTOMY; TUMOR DIAGNOSIS; TUMOR VOLUME; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; EVALUATION; METHODOLOGY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS; THREE DIMENSIONAL IMAGING;

ADULT; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 70249129039     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2523081423     Document Type: Article

References (39)

1. Stamey TA, McNeal JE, Freiha FS, Redwine E. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988;139(6):1235-1241. (Pubitemid 18151271)
2. McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 1992;23(3):258-266.
3. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Capsular penetration in prostate cancer: significance for natural history and treatment. Am J Surg Pathol 1990;14(3):240-247. (Pubitemid 20122226)
4. Villers AA, McNeal JE, Redwine EA, Freiha FS, Stamey TA. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol 1990;143(6):1183-1187. (Pubitemid 20193069)
5. Egevad L, Norberg M, Mattson S, Norlén BJ, Busch C. Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy. Urology 1998;52(4):653-658. (Pubitemid 28440175)
6. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 1990;66(6):1225-1233.
7. Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? a multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 1993;149(6):1478-1481. (Pubitemid 23164549)
8. Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 2004;172(2):508-511.
9. Bostwick DG, Graham SD Jr, Napalkov P, et al. Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 1993;41(5):403-411. (Pubitemid 23146459)
10. Noldus J, Stamey TA. Limitations of serum prostate specific antigen in predicting peripheral and transition zone cancer volumes as measured by correlation coefficients. J Urol 1996;155(1):232-237. (Pubitemid 126426471)
11. D'Amico AV, Chang H, Holupka E, et al. Calculated prostate cancer volume: the optimal predictor of actual cancer volume and pathologic stage. Urology 1997;49(3):385-391. (Pubitemid 27138681)
12. Palken M, Cobb OE, Warren BH, Hoak DC. Prostate cancer: correlation of digital rectal examination, transrectal ultrasound and prostate specific antigen levels with tumor volumes in radical prostatectomy specimens. J Urol 1990;143(6):1155-1162. (Pubitemid 20193061)
13. Kahn T, Bürrig K, Schmitz-Dräger B, Lewin JS, Fürst G, Mödder U. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. Radiology 1989;173(3):847-851. (Pubitemid 20007231)
14. Sanchez-Chapado M, Angulo JC, Ibarburen C, et al. Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer. Eur Urol 1997;32(2):140-149. (Pubitemid 27386951)
15. Ponchietti R, Di Loro F, Fanfani A, Amorosi A. Estimation of prostate cancer volume by endorectal coil magnetic resonance imaging vs pathologic volume. Eur Urol 1999;35(1):32-35. (Pubitemid 29080549)
16. Kirkham AP, Emberton M, Allen C. How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 2006;50(6):1163-1174.
17. Jager GJ, Ruijter ET, van de Kaa CA, et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 1996;166(4):845-852. (Pubitemid 26102064)
18. deSouza NM, Reinsberg SA, Scurr ED, Brewster JM, Payne GS. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 2007;80(950):90-95.
19. Sommer FG, Nghiem HV, Herfkens R, McNeal J, Low RN. Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil. AJR Am J Roentgenol 1993;161(1):81-86. (Pubitemid 23208753)
20. Coakley FV, Kurhanewicz J, Lu Y, et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 2002;223(1):91-97. (Pubitemid 34258194)
21. Villers A, Puech P, Mouton D, Leroy X, Ballereau C, Lemaitre L. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 2006;176(6 pt 1):2432-2437. (Pubitemid 44665992)
22. Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006;6:135-143.
23. Yoshimitsu K, Kiyoshima K, Irie H, et al. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging 2008;27(1):132-139.
24. Haider MA, van der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007;189(2):323-328. (Pubitemid 47195916)
25. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005;21(3):258-262. (Pubitemid 40280120)
26. Shimofusa R, Fujimoto H, Akamata H, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005;29(2):149-153.
27. Mazaheri Y, Shukla-Dave A, Hricak H, et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging - correlation with pathologic findings. Radiology 2008;246(2):480-488.
28. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29(3):162-173. (Pubitemid 26266657)
29. Yossepowitch O, Sircar K, Scardino PT, et al. Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. J Urol 2002;168(5):2011-2015.
30. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1(8476):307-310. (Pubitemid 16134762)
31. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45(1):255-268.
32. Barnhart HX, Lokhnygina Y, Kosinski AS, Haber M. Comparison of concordance correlation coefficient and coefficient of individual agreement in assessing agreement. J Biopharm Stat 2007;17(4):721-738. (Pubitemid 47027015)
33. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33(1):159-174.
34. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York, NY: Chapman & Hall, 1993.
35. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168(2):497-505. (Pubitemid 18184480)
36. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188(6):1622-1635. (Pubitemid 46866868)
37. deSouza NM, Riches SF, Vanas NJ, et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 2008;63(7):774-782.
38. Chan I, Wells W 3rd, Mulkern RV, et al. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging: a multichannel statistical classifier. Med Phys 2003;30(9):2390-2398.
39. Kurhanewicz J, Vigneron D, Carroll P, Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol 2008;18(1):71-77. (Pubitemid 350307535)